Test Price
2,800 AED✅ Home Collection Available
ELN Gene Cutis Laxa, Autosomal Dominant Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO-certified Next-Generation Sequencing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily 8 AM - 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance with a DHA-licensed genetic counsellor.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The ELN Gene Cutis Laxa Autosomal Dominant NGS Test detects pathogenic variants in the elastin gene, confirming a clinical diagnosis of autosomal dominant cutis laxa. Results inform accurate prognosis, family screening, and personalized management by a multidisciplinary team. The test employs complete gene sequencing using Next-Generation Sequencing (MiSeq/HiSeq) with CNV calling, ensuring detection of novel variants not identified by targeted mutation analysis.
| Feature | Our Test (ELN-NGS) | Closest Alternative (Targeted Mutation Analysis) |
|---|---|---|
| Precision | Complete gene sequencing; detects novel variants | Limited to known hotspots; misses private mutations |
| Method | Next-Generation Sequencing (MiSeq/HiSeq) with CNV calling | Sanger sequencing of selected exons |
| Speed | 3–4 Weeks TAT | 5–6 Weeks (fragmented reflex testing) |
| Clinical Relevance | Strong: Guides differential diagnosis, cardiovascular & pulmonary surveillance | Moderate: May require sequential testing; less prognostic value |
Physician Insight & Safety Protocols
"As a consultant medical geneticist, I understand the profound impact a genetic diagnosis can have. The ELN-NGS test provides a definitive molecular answer, but it must be interpreted in the context of complete family and clinical history. I encourage patients to share this report with their genetic counselor and treating physician for a comprehensive management plan." —Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403.
Advisory Note
⚠️ Medication Warning: Do not discontinue prescribed medication without consulting your doctor. This genetic test does not replace ongoing medical therapy.
Exclusion Criteria
- Inability to provide written informed consent (mandatory pre-test genetic counseling required).
- Acute psychiatric episode compromising understanding of test implications.
- Pregnancy where prenatal decision-making is not indicated (multidisciplinary approval needed).
- Age below 18 years without legal guardian consent.
If any red flag appears, seek immediate emergency care. For non-urgent queries, contact our clinical team via WhatsApp +971545488731.
Patient FAQ & Clinical Guidance
1. What is the ELN genetic test and why do I need it?
This NGS-based test sequences your entire ELN gene to identify disease-causing mutations responsible for autosomal dominant cutis laxa. It provides a definitive molecular diagnosis, helping your dermatologist and geneticist tailor surveillance for skin, lung, and heart complications.
2. How is the sample collected and when will I get results?
A certified phlebotomist collects a blood sample at your home using a temperature-controlled cold-chain VIP mobile service, with results in 3–4 weeks. Alternatively, you may submit extracted DNA or a dried blood card from your institution. All logistics comply with UAE PDPL for data privacy.
3. Does my insurance cover the 2800 AED cost of the test?
Many UAE insurance plans cover the 2800 AED ELN genetic test when pre-authorized by a dermatologist and geneticist referral. Our team provides direct billing verification via WhatsApp. We also assist with pre-certification documents citing medically necessary genetic testing coverage under UAE health regulations.
UAE Regulatory & Data Privacy Adherence
Data Privacy: Your genomic data is encrypted, stored exclusively within UAE borders, and never shared without your explicit consent, in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
Clinical Safety: All genetic testing follows Federal Decree-Law No. 4 of 2016 on Medical Liability, ensuring patient consent and clinical oversight.
Accreditations: ISO 9001:2015 Certified – Certificate INT/EGQ/2509DA/3139. DHA Facility License No. 1143.
Clinical & Logistical Metadata
| Test Name | ELN Gene Cutis Laxa, Autosomal Dominant Genetic Test (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood (3-5 mL in EDTA tube) — VIP Mobile Phlebotomy Available |
| Methodology Used | Next-Generation Sequencing (Illumina MiSeq/HiSeq) with CNV analysis |
| ICD-10-CM Code | Q82.8 (Congenital cutis laxa) |
| LOINC Code | 94093-8 (Elastin gene mutation analysis) |
| DHA Facility License & Laboratory Address | License No. 1143 — Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians